Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 224.44 AUD 2.66%
Market Cap: 23.5B AUD

Pro Medicus Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pro Medicus Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Pro Medicus Ltd
ASX:PME
Revenue
AU$190.9m
CAGR 3-Years
33%
CAGR 5-Years
29%
CAGR 10-Years
27%
Mach7 Technologies Ltd
ASX:M7T
Revenue
AU$34.4m
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
N/A
4DMedical Ltd
ASX:4DX
Revenue
AU$3.8m
CAGR 3-Years
159%
CAGR 5-Years
40%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Revenue
$47.2m
CAGR 3-Years
4%
CAGR 5-Years
19%
CAGR 10-Years
16%
Alcidion Group Ltd
ASX:ALC
Revenue
AU$35.6m
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
89%
S
Singular Health Group Ltd
ASX:SHG
Revenue
AU$945.8k
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Pro Medicus Ltd
Glance View

Economic Moat
Wide
Market Cap
23.5B AUD
Industry
Health Care

Pro Medicus Ltd, an Australian company founded in 1983, has etched its name in the field of healthcare IT, primarily through its innovative medical imaging software solutions. The brainchild of Dr. Sam Hupert and Anthony Hall, the company originally sought to provide radiology practices with digital solutions for image management and viewing. Over the years, Pro Medicus has meticulously evolved its offerings to become a leader in picture archiving and communication systems (PACS), radiology information systems (RIS), and an expanding range of e-health solutions. Its flagship product, Visage 7, is renowned for delivering fast and sophisticated viewing capabilities, enabling radiologists to efficiently interpret complex imaging data. Under its hood, the company’s technology is powered by advanced streaming capabilities, allowing for large files to be quickly accessed and reviewed, essential for high-demand environments. The monetization model of Pro Medicus largely revolves around licensing agreements for its software, alongside service and support fees, ensuring a steady and recurring revenue stream. The company has successfully leveraged its expertise to penetrate key markets, notably the United States and Europe, where it partners with some of the most prestigious hospitals and research institutions. By focusing on high-end offerings and fostering long-term client relationships, Pro Medicus has cemented a premium positioning in the healthcare IT landscape. The strategic focus on innovation, coupled with a keen understanding of the evolving needs of healthcare providers, allows Pro Medicus to continually refine its services, ensuring it remains at the forefront of technological advancements that ultimately enhance diagnostic efficiency and patient outcomes.

PME Intrinsic Value
37.94 AUD
Overvaluation 83%
Intrinsic Value
Price

See Also

What is Pro Medicus Ltd's Revenue?
Revenue
190.9m AUD

Based on the financial report for Dec 31, 2024, Pro Medicus Ltd's Revenue amounts to 190.9m AUD.

What is Pro Medicus Ltd's Revenue growth rate?
Revenue CAGR 10Y
27%

Over the last year, the Revenue growth was 31%. The average annual Revenue growth rates for Pro Medicus Ltd have been 33% over the past three years , 29% over the past five years , and 27% over the past ten years .

Back to Top